<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<?xml-stylesheet type="text/css" href="http://www.flintbox.com/include/style_rss.css" ?>
<rss version="2.0">
<channel>
<title>Flintbox | Flintbox technology feed</title>
<description>Updated with recent profiles and projects posted on Flintbox - FOR PERSONAL USE ONLY</description>
<link>http://www.flintbox.com/</link>
<lastBuildDate>Tue, 2 Feb 2010 16:18:57 PST</lastBuildDate>
<copyright>Copyright: (C) Flintbox, http://www.flintbox.com/terms.asp </copyright><image>
<title>Flintbox.com</title>
<url>http://www.flintbox.com/images/common/powered2.gif</url>
<link>http://www.flintbox.com/</link>
</image>
<item>
<title>nStudy</title>
<link>http://www.flintbox.com/technology.asp?page=4145</link>
<author><![CDATA[Simon Fraser University]]></author>
<description><![CDATA[Tools for enhancing learning and study in the digital age.]]></description>
<pubDate>Tue, 2 Feb 2010 16:18:57 PST</pubDate>
</item>
<item>
<title>Novel Nitric Oxide Donor-NSAIDs</title>
<link>http://www.flintbox.com/technology.asp?page=4143</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[In order to address the safety and efficiency issues regarding classical NSAIDs, researchers from the University of Alberta have designed a hybrid of NO-NSAID.]]></description>
<pubDate>Mon, 1 Feb 2010 9:17:51 PST</pubDate>
</item>
<item>
<title>LoxP xPress: a novel system for serial cloning</title>
<link>http://www.flintbox.com/technology.asp?page=4142</link>
<author><![CDATA[BC Cancer Agency]]></author>
<description><![CDATA[A series of novel  loxP spacer sites with the potential to be developed into a novel platform for powerfully expanding the potential of the routinely used Cre-LoxP system.]]></description>
<pubDate>Wed, 27 Jan 2010 9:21:43 PST</pubDate>
</item>
<item>
<title>Method and System for the Quantitative Chemical Speciation of Mercury and Other Toxic Pollutants</title>
<link>http://www.flintbox.com/technology.asp?page=4141</link>
<author><![CDATA[McGill University]]></author>
<description><![CDATA[The invention is a portable flow-system device which includes a gold and/or sulfur nanoparticle-based substrate to capture a sample (air, water).  The device is then mounted on a modified mass spectrometer to obtain both qualitative and quantitative chemical speciation date for mercury or other toxic pollutants contained in the sample.]]></description>
<pubDate>Wed, 27 Jan 2010 8:30:43 PST</pubDate>
</item>
<item>
<title>Online Single-pilot Resource Management Safety Training Program (OSRM&#8482;)</title>
<link>http://www.flintbox.com/technology.asp?page=2968</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[Advanced, affordable and entertaining safety training for general aviation pilots, delivered via the internet.]]></description>
<pubDate>Tue, 26 Jan 2010 9:43:39 PST</pubDate>
</item>
<item>
<title>In vitro human GI model to screen for drug candidates, nutraceuticals, food, etc.</title>
<link>http://www.flintbox.com/technology.asp?page=4140</link>
<author><![CDATA[McGill University]]></author>
<description><![CDATA[McGill University is offering a 
unique service based on an in vitro 
human GI tract system. Dr. Satya 
Prakash&#8217;s laboratory is the only
laboratory in North America
equipped with the Simulator of
Human Intestinal Microbial
Ecosystem (SHIME) device]]></description>
<pubDate>Mon, 25 Jan 2010 8:34:52 PST</pubDate>
</item>
<item>
<title>Cariology Probe For Dental Examination</title>
<link>http://www.flintbox.com/technology.asp?page=4139</link>
<author><![CDATA[McGill University]]></author>
<description><![CDATA[McGill University is seeking a company interested in developing and commercializing a new carious lesions detective probe (hand tool) for dental examination. A research team has designed a new probe for dental examination with specific features allowing for better detection of cavities.]]></description>
<pubDate>Mon, 25 Jan 2010 8:29:20 PST</pubDate>
</item>
<item>
<title>Digital microfluidic-based nanostructured SPR- imaging detection platform</title>
<link>http://www.flintbox.com/technology.asp?page=3592</link>
<author><![CDATA[McGill University]]></author>
<description><![CDATA[Research tool for detection of biological compounds (DNA, proteins, small molecules)]]></description>
<pubDate>Mon, 25 Jan 2010 8:18:21 PST</pubDate>
</item>
<item>
<title>Novel antibiotic chemistries: Aminoglycoside-based cationic amphiphiles</title>
<link>http://www.flintbox.com/technology.asp?page=4138</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This patent portfolio is available for licensing to qualified development partners]]></description>
<pubDate>Thu, 21 Jan 2010 10:16:04 PST</pubDate>
</item>
<item>
<title>Process for Treatment of Cereal Grains</title>
<link>http://www.flintbox.com/technology.asp?page=4137</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[A safe process for the treatment of cereal grains.  The treatment results in the prevention of rumen acidosis and a 40% increase in milk fat composition in dairy cows.]]></description>
<pubDate>Wed, 20 Jan 2010 8:19:59 PST</pubDate>
</item>
<item>
<title>Bone Marrow Derived Cells that Stimulate Pancreatic Regeneration in Type II Diabetes</title>
<link>http://www.flintbox.com/technology.asp?page=3037</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[The present invention relates to methods comprising of specialized mononuclear cells from bone marrow that can rescue hyperglycemia and augment pancreatic repair.]]></description>
<pubDate>Mon, 18 Jan 2010 9:43:35 PST</pubDate>
</item>
<item>
<title>McMaster PLUS&#8482;</title>
<link>http://www.flintbox.com/technology.asp?page=4039</link>
<author><![CDATA[McMaster University]]></author>
<description><![CDATA[Premium Literature Services for Evidence-Informed Health Care]]></description>
<pubDate>Wed, 13 Jan 2010 12:19:32 PST</pubDate>
</item>
<item>
<title>A Novel Class of Antibiotics</title>
<link>http://www.flintbox.com/technology.asp?page=2950</link>
<author><![CDATA[McMaster University]]></author>
<description><![CDATA[Three novel, cyclic, streptogramin-like antibiotics in which the ester bond has been replaced with a highly stable amide bond.  This results in enhanced stability against the Vgb inactivating enzymes while maintaining antibiotic activity.  Antibiotics function via a novel mode of action.]]></description>
<pubDate>Wed, 13 Jan 2010 12:18:38 PST</pubDate>
</item>
<item>
<title>A Specific Antibody for Mechanistic Indicators of Plaque Formation in Neurodegenerative Disease</title>
<link>http://www.flintbox.com/technology.asp?page=4136</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[Antibody that binds an epitope that holds promise to be sensitive and specific to ALS]]></description>
<pubDate>Thu, 7 Jan 2010 13:20:00 PST</pubDate>
</item>
<item>
<title>Treating Periprosthetic Fractures of the Femur</title>
<link>http://www.flintbox.com/technology.asp?page=3924</link>
<author><![CDATA[McMaster University]]></author>
<description><![CDATA[Novel apparatus increases healing rate of femoral
fractures]]></description>
<pubDate>Thu, 7 Jan 2010 10:22:27 PST</pubDate>
</item>
<item>
<title>Method to Boost Immune Responses</title>
<link>http://www.flintbox.com/technology.asp?page=3981</link>
<author><![CDATA[McMaster University]]></author>
<description><![CDATA[Novel prime:boost regimen elicits extremely strong immune response]]></description>
<pubDate>Thu, 7 Jan 2010 10:18:48 PST</pubDate>
</item>
<item>
<title>Diagnosing Peanut Allergy: SafeCall</title>
<link>http://www.flintbox.com/technology.asp?page=3918</link>
<author><![CDATA[McMaster University]]></author>
<description><![CDATA[A diagnostic algorithm for true peanut allergy that includes a series of demographic and biological variables that are hierarchically organized]]></description>
<pubDate>Thu, 7 Jan 2010 10:18:06 PST</pubDate>
</item>
<item>
<title>Novel Agent Displays Significant Anti-Viral and Anti-Tumour Properties</title>
<link>http://www.flintbox.com/technology.asp?page=3917</link>
<author><![CDATA[McMaster University]]></author>
<description><![CDATA[Researchers at McMaster University have discovered that delivery of a known bacterial associated protein induces a potent anti-viral response in vitro and in vivo.]]></description>
<pubDate>Thu, 7 Jan 2010 8:59:17 PST</pubDate>
</item>
<item>
<title>Stable Discovery Cell Lines for Autoimmune Disease Research - CTLA4 and its Mutants</title>
<link>http://www.flintbox.com/technology.asp?page=4133</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A leading immunologist at Robarts has generated a full spectrum of wild-type and mutant CTLA4 human cell constructs.]]></description>
<pubDate>Tue, 5 Jan 2010 13:39:05 PST</pubDate>
</item>
<item>
<title>Cell Culture Supplements for Generating Mature, Functional, Stabilized Blood Vessels In Vitro</title>
<link>http://www.flintbox.com/technology.asp?page=3718</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A novel combination of growth factors that may serve as a basis for promoting blood vessel formation in vitro as well as promoting of the investment of those vessels with smooth muscle cells.]]></description>
<pubDate>Mon, 21 Dec 2009 13:05:26 PST</pubDate>
</item>
<item>
<title>Expression of non-symbiotic hemoglobin improves yield through modifying plant phenotype</title>
<link>http://www.flintbox.com/technology.asp?page=4132</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This patented plant biotechnology is available for licensing to qualified development partners.]]></description>
<pubDate>Mon, 21 Dec 2009 13:00:15 PST</pubDate>
</item>
<item>
<title>Development of RNAi immunotherapeutics &amp; prognostic markers to treat and prevent progression of oral cancers at early stage</title>
<link>http://www.flintbox.com/technology.asp?page=4130</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This technology is the subject of a PCT application, which can be disclosed under a confidentiality agreement.]]></description>
<pubDate>Mon, 21 Dec 2009 12:21:50 PST</pubDate>
</item>
<item>
<title>Improved diagnostic test for estrogen receptor status in breast cancer &#8211; multiple phosphorylation state</title>
<link>http://www.flintbox.com/technology.asp?page=4129</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This patent portfolio is available for licensing to qualified development partners.]]></description>
<pubDate>Mon, 21 Dec 2009 12:17:36 PST</pubDate>
</item>
<item>
<title>Cosmeceutical Factors for Anti-Aging Applications</title>
<link>http://www.flintbox.com/technology.asp?page=4128</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A novel molecular pathway that prevents accelerated aging, enhances resistance to stress, and extends human cell lifespan while preserving physiologic function]]></description>
<pubDate>Mon, 21 Dec 2009 12:16:49 PST</pubDate>
</item>
<item>
<title>Self-assembling nanocluster dopants in LCs</title>
<link>http://www.flintbox.com/technology.asp?page=4127</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This patented self-assembling nanocluster dopant technology is available for licensing to qualified
development partners.]]></description>
<pubDate>Mon, 21 Dec 2009 8:58:21 PST</pubDate>
</item>
<item>
<title>Enhancing medication with directed drug convection using magnetic nano-particles</title>
<link>http://www.flintbox.com/technology.asp?page=4126</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This patented self-assembling nanocluster dopant technology is available for licensing to qualified development partners.]]></description>
<pubDate>Mon, 21 Dec 2009 8:46:42 PST</pubDate>
</item>
<item>
<title>Novel myocardial protection device</title>
<link>http://www.flintbox.com/technology.asp?page=4125</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This technology is the subject of a PCT application, which can be disclosed under a confidentiality agreement.]]></description>
<pubDate>Mon, 21 Dec 2009 8:30:56 PST</pubDate>
</item>
<item>
<title>Polymer free anti-restenotic, anti-platelet, endothelialization promoting coated stent</title>
<link>http://www.flintbox.com/technology.asp?page=4124</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This technology is the subject of a PCT application, which can be disclosed under a confidentiality agreement.]]></description>
<pubDate>Mon, 21 Dec 2009 8:25:17 PST</pubDate>
</item>
<item>
<title>Yellow mustard glucosinolate hydrolysis by starter cultures and use as a food antimicrobial</title>
<link>http://www.flintbox.com/technology.asp?page=4123</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[The new process uses flavourless deheated
yellow mustard flour which is activated by meat starter cultures to become potently antimicrobial
and thereby eliminate the risk of contamination by E. coli O157:H7 in these uncooked products.]]></description>
<pubDate>Mon, 21 Dec 2009 8:19:26 PST</pubDate>
</item>
<item>
<title>How to facilitate a successful simulation: An audio-video resource for clinical education facilitators and students</title>
<link>http://www.flintbox.com/technology.asp?page=4122</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[Clinical assessment of a patient is the key to a successful diagnosis and treatment. As more and more medical institutions start using high-fidelity simulators besides the conventional mannequins, the need to ensure adequate training of those facilitating these experiences assumes importance. Faculties are learning how to make the most of this technology as well as how to teach in this new environment. But audio-video (AV) aids to complement these gadgets
are lacking.]]></description>
<pubDate>Mon, 21 Dec 2009 8:11:16 PST</pubDate>
</item>
<item>
<title>Product and process to regulate a gene network involved in constitutive inflammation and early cancer progression</title>
<link>http://www.flintbox.com/technology.asp?page=4121</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[Cancers of the oral cavity are the 3rd most common malignancy of developing nations and 6th most common cancer in the developed world, resulting in several hundred thousands of deaths each year.]]></description>
<pubDate>Mon, 21 Dec 2009 7:29:59 PST</pubDate>
</item>
<item>
<title>Target, Compounds, and Discovery System for Limiting Scarring and Promoting Regeneration Following CNS Injury</title>
<link>http://www.flintbox.com/technology.asp?page=3038</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A Robarts&#8217; Scientist has identified a target molecule that can serve as a switch between scar establishment and regenerative matrix deposition by astroctye cells.]]></description>
<pubDate>Fri, 18 Dec 2009 11:48:14 PST</pubDate>
</item>
<item>
<title>Diagnostic test for bowen conradi-syndrome</title>
<link>http://www.flintbox.com/technology.asp?page=4120</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[Bowen Conradi Syndrome is an autosomal recessive disorder, with severely impaired prenatal growth, profound psychomotor retardation and death in early childhood. This genetic syndrome found exclusively among the Hutterites; a communal Anababtist group of 50,000 people of North Dakota and the Canadian prairies. Originating from the Southern Tyrol region, the disease originated as a founder effect in an initial population of 100. The birth prevalence of the syndrome is estimated to be 1/355, predicting a carrier
frequency of 1 in 10 in this population.]]></description>
<pubDate>Thu, 17 Dec 2009 13:27:37 PST</pubDate>
</item>
<item>
<title>Novel drug delivery method &#8211; a protein &#8220;cage&#8221;</title>
<link>http://www.flintbox.com/technology.asp?page=4119</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[Dr. Jorg Stetefeld has developed a novel way to deliver small molecule drugs within a protein &#8220;cage&#8221;.]]></description>
<pubDate>Thu, 17 Dec 2009 13:20:24 PST</pubDate>
</item>
<item>
<title>Novel cryptosporidium spp. vaccine</title>
<link>http://www.flintbox.com/technology.asp?page=4118</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[This technology provides two highly immunogenic Cryptosporidium antigens; immunodominant in cattle, rodents and humans.]]></description>
<pubDate>Thu, 17 Dec 2009 13:11:00 PST</pubDate>
</item>
<item>
<title>CAPSI web 2.0 teaching system</title>
<link>http://www.flintbox.com/technology.asp?page=4117</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[It is distributed to users (teachers and students alike) as a web service. CAPSI will help anyone who has something to teach.]]></description>
<pubDate>Thu, 17 Dec 2009 13:04:22 PST</pubDate>
</item>
<item>
<title>Treatment for septic shock: small molecule: A small molecule inhibitor of hydrogen peroxide cell signaling</title>
<link>http://www.flintbox.com/technology.asp?page=4116</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[Acute Sepsis is the second leading cause of death in non-coronary Intensive Care Unit patients and the tenth most common cause of death in the United States. It accounts for as much as 25% of ICU bed utilization. Mortality rates rise to between 40-50% when sepsis proceeds to a condition of Septic Shock which is a state of refractory arterial hypotension. To date, the best method for treating septic shock and accompanying cardiovascular dysfunction has been vasopressor therapy. There are no highly effective treatments that address the basic mechanisms of hemodynamic deterioration.]]></description>
<pubDate>Thu, 17 Dec 2009 12:56:31 PST</pubDate>
</item>
<item>
<title>In Situ polymerization of the inherently conducting polymer PEDOT.</title>
<link>http://www.flintbox.com/technology.asp?page=4115</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[Fulfilling the commercial potential of the nherently Conducting Polymers: The ICPs are promising materials, with wide potential application in the manufacture of OLEDS, printed circuits, batteries, capacitors, electromagnetic shielding and electrostatic charge dissipation coatings.]]></description>
<pubDate>Thu, 17 Dec 2009 12:48:19 PST</pubDate>
</item>
<item>
<title>Improved biodegradable edible plastics for films</title>
<link>http://www.flintbox.com/technology.asp?page=2298</link>
<author><![CDATA[University of Manitoba]]></author>
<description><![CDATA[The popularity of Listerine PocketPaks has led to a massive increase in the number of companies using edible film strips as a delivery method for their products.  In fact, in 2004 over 128 different products packaged as edible film strips were offered worldwide.  Edible film also has the potential to replace the oral pharmaceutical delivery market, as it is a more convenient and efficient system of drug delivery.
]]></description>
<pubDate>Thu, 17 Dec 2009 8:46:23 PST</pubDate>
</item>
<item>
<title>High Precision Radiostereometric Analysis (RSA) System for Monitoring Micro-Movement in Orthopedic Implants</title>
<link>http://www.flintbox.com/technology.asp?page=3715</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A new universal RSA calibration system that eliminates the need for joint-specific calibration boxes and analysis.  40% to 70% more accurate than existing technologies.]]></description>
<pubDate>Mon, 14 Dec 2009 13:18:26 PST</pubDate>
</item>
<item>
<title>Therapeutic Factors for Stabilizing Blood Vessels, Preventing Hemorrhage, and Promoting Angiogenesis following Ischemia</title>
<link>http://www.flintbox.com/technology.asp?page=3717</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A novel combination of growth factors that may serve as a basis for promoting blood vessel formation, and stabilizing those vessels whose stability may be compromised]]></description>
<pubDate>Mon, 14 Dec 2009 12:06:53 PST</pubDate>
</item>
<item>
<title>Electrochemical Biosensor for the Detection of HIV Enzymes</title>
<link>http://www.flintbox.com/technology.asp?page=4045</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[An inexpensive and easy-to-use method for early HIV detection]]></description>
<pubDate>Fri, 11 Dec 2009 11:26:04 PST</pubDate>
</item>
<item>
<title>Micro-Pressure Sensor</title>
<link>http://www.flintbox.com/technology.asp?page=3988</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A micro-photonic pressure sensor based on PC waveguides is fabricated using planar SOI technology.]]></description>
<pubDate>Fri, 11 Dec 2009 10:58:29 PST</pubDate>
</item>
<item>
<title>Nanowire-Supported Catalysts for Fuel Cells</title>
<link>http://www.flintbox.com/technology.asp?page=3311</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[This invention proposes nano-dimensioning that vastly increases the catalytic surface area available for reaction in a fuel cell.]]></description>
<pubDate>Thu, 10 Dec 2009 10:13:08 PST</pubDate>
</item>
<item>
<title>Polymer Nanocomposites Via a One-Step Synthesis Method</title>
<link>http://www.flintbox.com/technology.asp?page=2810</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[Western inventors have created some unique polymer nanocomposites which can be formed in one step]]></description>
<pubDate>Thu, 10 Dec 2009 9:07:54 PST</pubDate>
</item>
<item>
<title>Novel Strategy in Manipulation of Stem Cell Fate Specification</title>
<link>http://www.flintbox.com/technology.asp?page=3804</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A novel methodology of regulating and inducing stem cell differentiation by altering the expression of a key protein that is naturally existing and participating in embryo development]]></description>
<pubDate>Wed, 9 Dec 2009 13:31:37 PST</pubDate>
</item>
<item>
<title>Interactive Simulator for Otoscopy Training</title>
<link>http://www.flintbox.com/technology.asp?page=4110</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[3-D simulation software to improve otoscopy training]]></description>
<pubDate>Wed, 9 Dec 2009 13:06:49 PST</pubDate>
</item>
<item>
<title>A Magneto-Rheological-Based Clutch System for Robots</title>
<link>http://www.flintbox.com/technology.asp?page=4109</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[This technology uses magneto-rheological (MR) fluids in an actuation mechanism that connects a typical motor to a load.]]></description>
<pubDate>Wed, 9 Dec 2009 12:14:59 PST</pubDate>
</item>
<item>
<title>Ganglioside GM1 for treatment of Huntington&#8217;s Disease</title>
<link>http://www.flintbox.com/technology.asp?page=4105</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[Potential treatments for neurodegenerative diseases such as HD.]]></description>
<pubDate>Wed, 9 Dec 2009 10:34:33 PST</pubDate>
</item>
<item>
<title>Novel Potential Anti-Psychotic Agents</title>
<link>http://www.flintbox.com/technology.asp?page=4104</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[Novel analogues of &#223;-phenylethylidenehydrazine (PEH) with implications in the treatment of schizophrenia.]]></description>
<pubDate>Wed, 9 Dec 2009 10:23:25 PST</pubDate>
</item>
<item>
<title>Cysteine rich protein (CRISP1), a reliable marker for replacing and/or complementing various male infertility assessment procedures</title>
<link>http://www.flintbox.com/technology.asp?page=4103</link>
<author><![CDATA[Universit&#233; Laval]]></author>
<description><![CDATA[A greatly facilitating testing kit based on a new cysteine-rich secretory protein (CRISP1) highly specific to the epididymis to be used for male infertility assessment procedures.]]></description>
<pubDate>Thu, 3 Dec 2009 14:15:38 PST</pubDate>
</item>
<item>
<title>In-Source Atmospheric Pressure-Electron Capture Dissociation (AP-ECD)</title>
<link>http://www.flintbox.com/technology.asp?page=4102</link>
<author><![CDATA[University of British Columbia - UBC]]></author>
<description><![CDATA[A New Tool for Mass Spectrometric Analysis of Peptides and Proteins]]></description>
<pubDate>Wed, 2 Dec 2009 10:04:08 PST</pubDate>
</item>
<item>
<title>Flexible BioElectronic Photodetector and Imaging Arrays</title>
<link>http://www.flintbox.com/technology.asp?page=3312</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[The invention relates to the design and fabrication of photodetector arrays and non-traditional imaging systems that exploit bacteriorhodopsin (bR) thin films and flexible printed electronic circuits.]]></description>
<pubDate>Tue, 1 Dec 2009 13:49:40 PST</pubDate>
</item>
<item>
<title>Electroflotation process for the conditioning of animal manure</title>
<link>http://www.flintbox.com/technology.asp?page=4100</link>
<author><![CDATA[Agriculture and Agri-Food Canada - Agriculture et Agroalimentaire Canada]]></author>
<description><![CDATA[A research team from Agriculture and Agri-Food Canada (AAFC), together with a team from the Research and Development Institute for the Agri-Environment (IRDA), has developed a new process for conditioning animal manure.  This new process deals well with the problem of excess fertilizing agents while also reducing pathogens and odours.  Companies interested in obtaining a licence for this technology or carrying out a joint research and development project must contact the IRDA.]]></description>
<pubDate>Tue, 1 Dec 2009 11:20:01 PST</pubDate>
</item>
<item>
<title>Image Reconstruction Technology for Gradient Camera and Machine Vision System</title>
<link>http://www.flintbox.com/technology.asp?page=4099</link>
<author><![CDATA[University of Victoria]]></author>
<description><![CDATA[It is a novel method to efficiently reconstruct digital images particularly of high contrast scenes without experiencing the so-called saturation effect, an imaging problem due to the limited dynamic range of conventional digital cameras. The proprietary algorithm for this technology is based on the wavelet decomposition and synthesis of gradient measurements.]]></description>
<pubDate>Thu, 26 Nov 2009 9:35:36 PST</pubDate>
</item>
<item>
<title>Value Your Elders: A Case Study</title>
<link>http://www.flintbox.com/technology.asp?page=4098</link>
<author><![CDATA[University of Victoria]]></author>
<description><![CDATA[A video for nursing students to entice interest in gerontological care.]]></description>
<pubDate>Wed, 25 Nov 2009 16:17:36 PST</pubDate>
</item>
<item>
<title>Short term stock market forecasting tool</title>
<link>http://www.flintbox.com/technology.asp?page=4097</link>
<author><![CDATA[McGill University]]></author>
<description><![CDATA[McGill University researchers have developed a software program to make day to day predictions of stock price variations. The prediction algorithm is based on a new hypothesis about the predictability of stock prices: the &#8220;Live Market Hypothesis&#8221;.  McGill University is looking for users to further test and validate the prediction model, and for partners to commercialize the software.]]></description>
<pubDate>Tue, 24 Nov 2009 7:59:21 PST</pubDate>
</item>
<item>
<title>Bc Milk Producers</title>
<link>http://www.flintbox.com/profile_ia.asp?page=765</link>
<author><![CDATA[Bc Milk Producers]]></author>
<description><![CDATA[&lt;p&gt;British Columbia Milk Producers Association (BCMPA) is the voice of all dairy farmers in British Columbia, since it was founded in 1936 under the name of BC Federation of Agriculture. We are advocates with governments, the media, special interest groups and environmentalists, and other industry associations. Our purpose is to advance the legitimate business interest of this province's dairy farmers and promote a vibrant, sustainable industry which supplies high quality dairy products to the consumer. &lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;We represent approximately 600 commercial dairy producers who milk 75,000 cows daily. Delegates from BC's eight regions are appointed to serve on the BCMPA board of directors on three-year terms. As the umbrella organization, it is the BCMPA's role to represent all regions provincially and federally. &lt;/p&gt;
&lt;p&gt;We support and work closely with the Dairy Farmers of Canada through the six BCMPA delegates nominated to represent BC's interest at their Annual General Meeting and Policy Conference. Dairy Farmers of Canada is the group that deals with national dairy issues including policy, lobbying and trade, and market development for industrial products. &lt;/p&gt;
&lt;p&gt;In this province, BC Milk Producers Association works closely with BC Dairy Foundation who deal with fluid milk promotion and nutrition issues. We support the BC Agriculture Council and the Canadian Federation of Agriculture as well as provide representatives to over 35 groups, committees and boards throughout the agriculture industry&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 15:47:07 PST</pubDate>
</item>
<item>
<title>Bc Innovation Council</title>
<link>http://www.flintbox.com/profile_ia.asp?page=764</link>
<author><![CDATA[Bc Innovation Council]]></author>
<description><![CDATA[&lt;p&gt;BCIC EXPANDS INNOVATION by providing a one-stop point of access and support to high technology companies, educational institutions, technology industry awareness groups, federal science and technology agencies and university research labs. By leveraging resources from federal, private and commercial institutions, we support the transfer of leading edge research into industry and accelerate commercialization of world-class, technology-based products for the economic benefit of BC&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 15:46:15 PST</pubDate>
</item>
<item>
<title>Aversa, Gregorio</title>
<link>http://www.flintbox.com/profile_ia.asp?page=763</link>
<author><![CDATA[Aversa, Gregorio]]></author>
<description><![CDATA[&lt;p&gt;individual&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 15:45:36 PST</pubDate>
</item>
<item>
<title>Aurora Biomed Inc.</title>
<link>http://www.flintbox.com/profile_ia.asp?page=225</link>
<author><![CDATA[Aurora Biomed Inc.]]></author>
<description><![CDATA[&lt;p&gt;Aurora Biomed manufactures systems for high throughput drug discovery and ion channel screening.&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 15:26:11 PST</pubDate>
</item>
<item>
<title>Augurex Life Sciences Corp.</title>
<link>http://www.flintbox.com/profile_ia.asp?page=762</link>
<author><![CDATA[Augurex Life Sciences Corp.]]></author>
<description><![CDATA[&lt;p&gt;Augurex Life Sciences Corp. develops biomarker technologies to screen people for diseases that when identified can be promptly treated, thereby delivering the benefit of earlier detection and greater treatment success. Biomarker screening tools can also be used to optimize a person&amp;rsquo;s therapy by predicting which treatment will personally offer them maximum therapeutic benefit while minimizing their side effects. Hence our signature; Identify, Optimize, Personalize. &lt;br /&gt;&lt;br /&gt;Augurex&amp;rsquo;s lead technology, AGX-020 is a novel biomarker of arthritis which is being developed as a simple blood test to help doctors determine the degree of structural damage in the joint, thereby providing an alternative to x-rays. &lt;br /&gt;&lt;br /&gt;Augurex identifies early-stage biomarkers and focuses on their scientific and clinical advancement while partnering their commercial entry into the market, thereby making them globally accessible to patients and healthcare providers.&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 15:25:34 PST</pubDate>
</item>
<item>
<title>ASKA Research</title>
<link>http://www.flintbox.com/profile_ia.asp?page=760</link>
<author><![CDATA[ASKA Research]]></author>
<description><![CDATA[&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;743&quot;&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td class=&quot;content&quot; width=&quot;219&quot; valign=&quot;top&quot;&gt;ASKA Research provides a full range of multi-centre clinical trial management and monitoring services from project conception to marketing approval.&lt;br /&gt;&lt;br /&gt;We apply high-level expertise, experience and resources in monitoring and managing Phase I-IV trials in North America. ASKA Research works with the pharmaceutical, biotechnology and biologics industries, as well as federally funded research organizations such as CIHR and NIH. &lt;/td&gt;
&lt;td&gt;&lt;img src=&quot;images/spacer.gif&quot; border=&quot;0&quot; alt=&quot;ASKA Research&quot; width=&quot;45&quot; height=&quot;1&quot; /&gt;&lt;/td&gt;
&lt;td class=&quot;content&quot; width=&quot;217&quot; valign=&quot;top&quot;&gt;Through one point of contact, you have access to our Research Professionals Network (RPN) of established clinical research professionals, our collaborative partner organizations, and our CRO alliance partners in the United States, Europe and the Asia-Pacific region.&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 15:22:51 PST</pubDate>
</item>
<item>
<title>ARCH Venture Partners</title>
<link>http://www.flintbox.com/profile_ia.asp?page=759</link>
<author><![CDATA[ARCH Venture Partners]]></author>
<description><![CDATA[&lt;p&gt;ARCH Venture Partners invests in the development of seed and early stage technology companies that have the potential to grow rapidly into successful businesses.&lt;br /&gt;&lt;br /&gt;ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences, physical sciences, and information technology. We enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 15:18:32 PST</pubDate>
</item>
<item>
<title>Arbutus Dental Centre</title>
<link>http://www.flintbox.com/profile_ia.asp?page=758</link>
<author><![CDATA[Arbutus Dental Centre]]></author>
<description><![CDATA[&lt;p&gt;other&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 15:07:22 PST</pubDate>
</item>
<item>
<title>Alphalyse Inc.</title>
<link>http://www.flintbox.com/profile_ia.asp?page=757</link>
<author><![CDATA[Alphalyse Inc.]]></author>
<description><![CDATA[&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Alphalyse&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt; is a contract service organization that provides protein analysis services to biotech, pharma and academia to support the development and manufacturing of natural and recombinant proteins. The analysis includes advanced mass spectrometry methods for protein identification, characterization and quantification. Alphalyse has offices in the USA (Palo Alto, CA), Canada (Vancouver, British Columbia) and in Europe (Odense, Denmark).&lt;/span&gt;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&amp;nbsp;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Alphalyse offers Pick-n-Post protein analysis services as well as customized contract services.&lt;/span&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Pick 'n Post Services:&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Pick 'n Post (&lt;a href=&quot;http://www.pick-n-post.com/&quot;&gt;www.pick-n-post.com&lt;/a&gt;) are fast and high-quality protein analysis services offered to research scientists in biotech, pharma and academia. Your samples are easily prepared, packed and conveniently shipped by express courier using our free Pick 'n Post kits. A detailed result report is returned within 2-8 days.&lt;br /&gt;&lt;br /&gt;Choose from these easy to use Pick &amp;lsquo;n Post services:&lt;/span&gt;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&amp;nbsp;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;margin: 0in 0in 0pt 0.25in; text-indent: -0.25in; mso-add-space: auto;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Protein Identification of bands &amp;amp; spots from 1D/2D SDS PAGE gels.&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin: 0in 0in 0pt 0.25in; text-indent: -0.25in; mso-add-space: auto;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;N-terminal Sequencing of proteins and peptides.&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin: 0in 0in 0pt 0.25in; text-indent: -0.25in; mso-add-space: auto;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Amino Acid Analysis of proteins and peptides.&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin: 0in 0in 0pt 0.25in; text-indent: -0.25in; mso-add-space: auto;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Molecular Weight Determination of proteins and peptides.&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Custom Contract Services:&lt;/span&gt;&lt;/strong&gt;&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;strong style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt;&quot;&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;Alphalyse also offers a range of custom designed protein analysis services.&lt;/span&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt; &lt;/span&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;span&gt;Protein Quantification &amp;ndash; Alpha-Quant&amp;trade; &lt;/span&gt;&lt;span&gt;N- and C-terminal Sequencing by MALDI ISD &lt;/span&gt;&lt;span&gt;Host Cell Protein Assay &lt;/span&gt;&lt;span&gt;Cell Line Development &lt;/span&gt;&lt;span&gt;Protein Characterization&lt;/span&gt;&lt;span style=&quot;font-size: 8pt; line-height: 115%; font-family: 'verdana','sans-serif';&quot;&gt;: Post-translational modification (phosphorylation, glycosylation etc.)&lt;/span&gt; &lt;/li&gt;
&lt;/ul&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 14:57:17 PST</pubDate>
</item>
<item>
<title>Alectos Therapeutics</title>
<link>http://www.flintbox.com/profile_ia.asp?page=838</link>
<author><![CDATA[Alectos Therapeutics]]></author>
<description><![CDATA[&lt;p&gt;&lt;span style=&quot;font-size: 14px;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;color: #3c7fb8; font-family: Helvetica;&quot;&gt;Innovative New Therapies for Unmet Medical Needs&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 14:48:21 PST</pubDate>
</item>
<item>
<title>Alexander, Chris</title>
<link>http://www.flintbox.com/profile_ia.asp?page=774</link>
<author><![CDATA[Alexander, Chris]]></author>
<description><![CDATA[&lt;p&gt;Individual&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 14:44:46 PST</pubDate>
</item>
<item>
<title>Ag-West Bio Inc.</title>
<link>http://www.flintbox.com/profile_ia.asp?page=756</link>
<author><![CDATA[Ag-West Bio Inc.]]></author>
<description><![CDATA[&lt;p&gt;Ag-West Bio is a membership-based organization at the forefront of Saskatchewan's bio-economy. We work as a catalyst for partnerships and industry growth by providing seed capital, aiding strategic alliances, providing regulatory support and communications. Our membership includes corporations, associations and individuals representing natural health products and functional foods, bioproducts and bioprocesses, and agricultural biotechnology sectors.&lt;/p&gt;
&lt;h2&gt;&lt;br /&gt;Vision&lt;/h2&gt;
&lt;p&gt;Saskatchewan&amp;rsquo;s catalyst for building Canada&amp;rsquo;s most vibrant Ag-bioeconomy.&lt;br /&gt;&amp;nbsp;&lt;/p&gt;
&lt;h3&gt;Mission&lt;/h3&gt;
&lt;!--don't change to h2...or the 2 paragraphs preceding will disappear on rollover in IE6WIN--&gt;
&lt;p&gt;Proactively enable the development and commercialization of innovation by linking research to industry for a diversified Saskatchewan Economy.&lt;br /&gt;&amp;nbsp;&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 14:39:54 PST</pubDate>
</item>
<item>
<title>Acetech</title>
<link>http://www.flintbox.com/profile_ia.asp?page=754</link>
<author><![CDATA[Acetech]]></author>
<description><![CDATA[&lt;p&gt;ACETECH delivers what is for many, a profound experience. Dedicated exclusively to CEOs and Past-CEOs of technology and life sciences companies, everything about ACETECH is geared to the unique environment of the chief executive role. If you are committed to improving your performance as an executive and a leader, your participation in ACETECH will be rewarded with the highest level of learning and growth. ACETECH is an on-going opportunity to connect with the best and the brightest stars in the technology field.&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 14:38:25 PST</pubDate>
</item>
<item>
<title>Abnousi Financial Consultants</title>
<link>http://www.flintbox.com/profile_ia.asp?page=755</link>
<author><![CDATA[Abnousi Financial Consultants]]></author>
<description><![CDATA[&lt;p&gt;Abnousi Financial Consultants (AFC) is a Vancouver based financial advisory firm.&amp;nbsp; AFC specializes in providing Accounting, Corporate Finance and Management Services to technology and life science clients.&lt;/p&gt;]]></description>
<pubDate>Tue, 17 Nov 2009 14:06:44 PST</pubDate>
</item>
<item>
<title>Circulating Fluidized Beds for Continuous Protein Refolding</title>
<link>http://www.flintbox.com/technology.asp?page=2729</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[This technology enables the continuous handling of heterologous inclusion proteins, minimizing the attrition often seen from repeated batch handling.]]></description>
<pubDate>Fri, 13 Nov 2009 13:15:48 PST</pubDate>
</item>
<item>
<title>Biological Nutrient Removal by Modified MBR System</title>
<link>http://www.flintbox.com/technology.asp?page=2725</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A new, compact, highly efficient wastewater treatment process employing an MBR unit.]]></description>
<pubDate>Fri, 13 Nov 2009 9:26:05 PST</pubDate>
</item>
<item>
<title>Adsorbent Activity Characterization by Electrical Measurements (Capacitance Sensor)</title>
<link>http://www.flintbox.com/technology.asp?page=399</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[University of Western Ontario researchers have developed a method and apparatus to measure changes in conductivity as an indicator of the relative adsorbent capacity of an absorptive substance such as alumina, molecular sieves and activated charcoal.]]></description>
<pubDate>Fri, 13 Nov 2009 8:50:41 PST</pubDate>
</item>
<item>
<title>Method of Energy Production Using Slurry of Coal in Liquid Bio-fuels</title>
<link>http://www.flintbox.com/technology.asp?page=4060</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A novel process which combines coal with bio-oil derived from biomass and has the potential to reduce greenhouse gas emissions, as well as coal consumption, by 30%]]></description>
<pubDate>Fri, 13 Nov 2009 8:03:45 PST</pubDate>
</item>
<item>
<title>Hydrophobic Paints and Coatings</title>
<link>http://www.flintbox.com/technology.asp?page=3419</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[Novel coatings have been demonstrated to provide super-hydrophobic (Contact Angle &gt; 160&#186;) properties which has unlimited potential applications in many industrial sectors, including aerospace]]></description>
<pubDate>Fri, 13 Nov 2009 8:01:52 PST</pubDate>
</item>
<item>
<title>Waste Water Treatment System</title>
<link>http://www.flintbox.com/technology.asp?page=403</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[University of Western Ontario researchers have designed a new, compact, highly efficient waste water treatment process, using a liquid-solid circulating fluidized bed system.]]></description>
<pubDate>Fri, 13 Nov 2009 7:53:01 PST</pubDate>
</item>
<item>
<title>Less Lethal Ammunition for Peace Keeping</title>
<link>http://www.flintbox.com/technology.asp?page=615</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A less lethal ammunition that addresses accuracy, material property changes in cold climates, and the use of lead.]]></description>
<pubDate>Fri, 13 Nov 2009 7:48:38 PST</pubDate>
</item>
<item>
<title>Powder Paint Fluidization Additives</title>
<link>http://www.flintbox.com/technology.asp?page=422</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[Novel additives have been demonstrated to provide excellent fluidization of ultra-fine powders both in the laboratory and in an industrial powder coating process.
]]></description>
<pubDate>Fri, 13 Nov 2009 7:46:11 PST</pubDate>
</item>
<item>
<title>Sirona Biochem Corp</title>
<link>http://www.flintbox.com/profile_ia.asp?page=786</link>
<author><![CDATA[Sirona Biochem Corp]]></author>
<description><![CDATA[&lt;p style=&quot;margin: 0in 0in 0pt;&quot;&gt;&lt;span style=&quot;font-family: 'verdana','sans-serif'; font-size: 9pt; mso-bidi-font-family: arial;&quot;&gt;&lt;strong&gt;Sirona Biochem Corp.&lt;/strong&gt; (TSX: V - SBM) is an emerging biotech company dedicated to the discovery and development of novel drug compounds. The current focus is on treatments for Type II diabetes and obesity. Sirona has entered into a license agreement with TFChem S.A&lt;span style=&quot;color: #000000;&quot;&gt;.R.L., a drug discovery company based in Rouen, France. TFChem licenses its technology of fluorinated carbohydrate mimics: GlycoMim&amp;reg;, and products in development, to biotech companies. The license agreement with TFChem provides for research and development of new compounds known as SGLT Inhibitors. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt;&quot;&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt;&quot;&gt;&lt;span style=&quot;font-family: 'verdana','sans-serif'; color: #000000; font-size: 9pt; mso-bidi-font-family: arial;&quot;&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;]]></description>
<pubDate>Mon, 9 Nov 2009 11:28:24 PST</pubDate>
</item>
<item>
<title>NF-kB : a prognostic marker of prostate cancer</title>
<link>http://www.flintbox.com/technology.asp?page=4096</link>
<author><![CDATA[CHUM]]></author>
<description><![CDATA[NF-kB predicts aggressiveness of prostate cancer to optimize therapy regimen.

MoA : Detection of NF-kB in the nucleus where an increase correlates with the development of metastases.

NF-kB antibodies are detected by immunohistochemistry on biopsy.

Applications : Screening to determine the prognostic of prostate cancer; improves the predictive power when used in combination with other known prognostic markers such as Gleason grade, pathological stage and prostate specific antigen (PSA).

PoP : Prediction of bone metastasis in a study of 30 radical prostatectomy specimens (BJU int, March 2003); A second study with 706 samples (Urological Association, Quebec, 2007); Ongoing validation supported by a MDEIE grant to prove the concept on samples from 2300 patients.]]></description>
<pubDate>Mon, 9 Nov 2009 7:46:49 PST</pubDate>
</item>
<item>
<title>Wisdahl Consulting Group</title>
<link>http://www.flintbox.com/profile_ia.asp?page=629</link>
<author><![CDATA[Wisdahl Consulting Group]]></author>
<description><![CDATA[Wisdahl Consulting Group (WCG) provides consulting services to small and mid sized medical device companies looking for assistance with Regulatory Affairs, Clinical Research &amp; Quality Assurance issues, as well as Human Resources and Accounting challenges.]]></description>
<pubDate>Fri, 6 Nov 2009 15:28:13 PST</pubDate>
</item>
<item>
<title>Patient-Specific Surgical Guide with Intraoperative Adjustability</title>
<link>http://www.flintbox.com/technology.asp?page=4095</link>
<author><![CDATA[Queen's University]]></author>
<description><![CDATA[Patient-specific guide that employs a verification tool and adjustable instrument sleeves to alter, if necessary, the surgical approach provided by the guide.]]></description>
<pubDate>Fri, 6 Nov 2009 13:35:01 PST</pubDate>
</item>
<item>
<title>Extended Release Absorbable Polymer Drug Delivery Systems</title>
<link>http://www.flintbox.com/technology.asp?page=4094</link>
<author><![CDATA[Queen's University]]></author>
<description><![CDATA[A researcher at Queen&#8217;s University has developed a suite of proprietary extended release drug delivery systems based on absorbable elastomers and injectable polymers. Formulated from clinically accepted monomers such as D,L-lactide, E-caprolactone, polyethylene glycol, and trimethylene carbonate, these novel drug delivery systems can be tailored to possess a specific drug release profile, surface chemistry, and/or resorption rate and have been tested with a variety of therapeutic agents including proteins and peptides.]]></description>
<pubDate>Fri, 6 Nov 2009 13:23:51 PST</pubDate>
</item>
<item>
<title>Decellularized Adipose Tissue for Soft Tissue Augmentation</title>
<link>http://www.flintbox.com/technology.asp?page=4093</link>
<author><![CDATA[Queen's University]]></author>
<description><![CDATA[A researcher at Queen&#8217;s University has developed a detergent-free and collagenase-free method of processing adipose tissue that yields an intact extracellular matrix with significant architecture and volume, but that is devoid of cells.]]></description>
<pubDate>Fri, 6 Nov 2009 13:10:03 PST</pubDate>
</item>
<item>
<title>Low Complexity Multi-User Detection System for TH-UWB Networks</title>
<link>http://www.flintbox.com/technology.asp?page=4092</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[Researchers at the University of Alberta&#8217;s iCORE Wireless Communications Laboratory have developed a novel &#8220;multisampling&#8221; multi-user detection method for TH-UWB transmission systems that greatly reduces the complexity of the transmitter and receiver and much more effectively accounts for the noise produced by multiple users in a system.]]></description>
<pubDate>Mon, 2 Nov 2009 3:06:34 PST</pubDate>
</item>
<item>
<title>Optimal Linear Rake Combiner for Multipath Signals in Noisy Environments</title>
<link>http://www.flintbox.com/technology.asp?page=4091</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[Researchers at the University of Alberta&#8217;s iCORE Wireless Communications Laboratory have developed a new optimal linear rake combiner that compensates for the presence of symmetric alpha-stable type noise, rather than simply the noise that can be modeled as Gaussian.]]></description>
<pubDate>Mon, 2 Nov 2009 2:50:15 PST</pubDate>
</item>
<item>
<title>CryoSim</title>
<link>http://www.flintbox.com/technology.asp?page=4090</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[A novel technique for stem-cell storage and preservation]]></description>
<pubDate>Fri, 30 Oct 2009 10:12:33 PST</pubDate>
</item>
<item>
<title>Robust Wireless MISO Scheme With Minimal Feedback</title>
<link>http://www.flintbox.com/technology.asp?page=4089</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[Researchers at the University of Alberta&#8217;s iCORE Wireless Communications Laboratory have developed a new wireless transmission scheme based on quantized feedback transmitter diversity.]]></description>
<pubDate>Fri, 30 Oct 2009 7:51:04 PST</pubDate>
</item>
<item>
<title>Low Complexity Optimal and Iterative UWB Receiver Structures</title>
<link>http://www.flintbox.com/technology.asp?page=4088</link>
<author><![CDATA[University of Alberta]]></author>
<description><![CDATA[Researchers at the University of Alberta&#8217;s iCORE Wireless Communications Laboratory have developed four new transmitted reference receiver structures that further lower the complexity of Ultra Wide Bandwidth systems while increasing the performance, each best applied to different circumstances and signal environments.]]></description>
<pubDate>Fri, 30 Oct 2009 6:14:42 PST</pubDate>
</item>
<item>
<title>NutriSTEP&#174;</title>
<link>http://www.flintbox.com/technology.asp?page=3586</link>
<author><![CDATA[University of Guelph]]></author>
<description><![CDATA[A nutrition risk screening tool for preschool children, aged 3-5 years.  Valid, reliable, bilingual (English and French). French Toolkit &amp; Questionnaire are now available.]]></description>
<pubDate>Thu, 29 Oct 2009 8:30:47 PST</pubDate>
</item>
<item>
<title>OncoGenex Technologies Inc.</title>
<link>http://www.flintbox.com/profile_ia.asp?page=111</link>
<author><![CDATA[OncoGenex Technologies Inc.]]></author>
<description><![CDATA[OncoGenex Technologies Inc. is a clinical-stage biotechnology company developing targeted therapeutics for Cancer. OncoGenex has built a solid product portfolio, recruited a highly skilled and experienced management team and Board of Directors, and has established strategic alliances that enable rapid drug development and access to state-of-the-art technology.]]></description>
<pubDate>Wed, 28 Oct 2009 9:37:39 PST</pubDate>
</item>
<item>
<title>Cardiome Pharma Corp.</title>
<link>http://www.flintbox.com/profile_ia.asp?page=189</link>
<author><![CDATA[Cardiome Pharma Corp.]]></author>
<description><![CDATA[Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function.]]></description>
<pubDate>Tue, 27 Oct 2009 15:39:35 PST</pubDate>
</item>
<item>
<title>SW-01: Novel Anti-Cancer Compound</title>
<link>http://www.flintbox.com/technology.asp?page=4087</link>
<author><![CDATA[Queen's University]]></author>
<description><![CDATA[Researchers at Queen&#8217;s University have identified a genericized drug compound, SW-01, specific for inhibiting the RET receptor tyrosine kinase.  SW-01 has powerful anti-cancer properties and is effective in reducing pancreatic cancer tumours in a number of in vivo preclinical models. This compound has the potential for treating a number of cancer types involving RET.]]></description>
<pubDate>Fri, 23 Oct 2009 13:34:52 PST</pubDate>
</item>
<item>
<title>Follicular Lymphoma Predictive Assay</title>
<link>http://www.flintbox.com/technology.asp?page=4086</link>
<author><![CDATA[Queen's University]]></author>
<description><![CDATA[The Follicular Lymphoma Assay uses gene pairs identified from expression arrays of tissues from FL patients and can predict 5 year mortality with greater than 85% accuracy.]]></description>
<pubDate>Fri, 23 Oct 2009 13:00:52 PST</pubDate>
</item>
<item>
<title>Endoglycan mAb</title>
<link>http://www.flintbox.com/technology.asp?page=4059</link>
<author><![CDATA[University of British Columbia - UBC]]></author>
<description><![CDATA[This antibody (F4B10) is optimized for use on FACS and live cells. It has also been validated for use in immunoprecipitation (IP).]]></description>
<pubDate>Wed, 21 Oct 2009 14:27:47 PST</pubDate>
</item>
<item>
<title>ANKtide:  Chemotherapeutic Peptide for Metastatic Cancer</title>
<link>http://www.flintbox.com/technology.asp?page=4085</link>
<author><![CDATA[Queen's University]]></author>
<description><![CDATA[Researchers at Queen&#8217;s University have developed a novel peptide (ANKtide) that is effective in reducing breast cancer tumours in vivo preclinical models. The peptide holds promise as a novel chemotherapeutic for metastatic cancers.]]></description>
<pubDate>Tue, 20 Oct 2009 10:45:16 PST</pubDate>
</item>
<item>
<title>&#8220;The Fourth R&#8221;: Strategies for Healthy Youth Relationships</title>
<link>http://www.flintbox.com/technology.asp?page=4084</link>
<author><![CDATA[WORLDiscoveries]]></author>
<description><![CDATA[A comprehensive, evidence-based program to help schools and communities reduce violence and risk-taking among youth]]></description>
<pubDate>Wed, 14 Oct 2009 12:21:17 PST</pubDate>
</item>
<item>
<title>Vaccine Comprising Heat Sensitive Transgene</title>
<link>http://www.flintbox.com/technology.asp?page=4083</link>
<author><![CDATA[University of Victoria]]></author>
<description><![CDATA[Genes derived from psychrophilic bacteria are used to replace a homologous essential gene in a mesophilic pathogen rendering it temperature sensitive. This has been optimized so that it is extremely sensitive and specific and can have a restrictive temperature at about that of the human body core; this allows that pathogen to survive in the slightly lower temperature that is common in the extremities thereby inducing an immune response, but because it is unable to survive at the slightly elevated temperature of the core it is unable to produce a full fledged attack on its host.]]></description>
<pubDate>Tue, 13 Oct 2009 14:41:53 PST</pubDate>
</item>
<item>
<title>Treatment and Prevention of Ischemic Injury Using Activated Protein C</title>
<link>http://www.flintbox.com/technology.asp?page=4081</link>
<author><![CDATA[Dalhousie University]]></author>
<description><![CDATA[The use of APC as a therapeutic agent for flap ischemia prevention in reconstructive surgery.]]></description>
<pubDate>Fri, 9 Oct 2009 6:08:06 PST</pubDate>
</item>
</channel>
</rss>
